Lung Cancer

Editorial board
pp. CO2-CO2(1)

Contents
pp. iii-iii(1)

Contents continued
pp. iv-iv(1)

A global approach to tobacco policy
pp. 113-117(5)
Author: Gray N.

Is it more important to quit smoking than which chemotherapy is used?
pp. 119-124(6)
Author: Dresler C.M.

Gelatinolytic activity of matrix metalloproteinase in lung cancer studied using film in situ zymography stamp method
pp. 125-130(6)
Authors: Kaji M.; Moriyama S.; Sasaki H.; Saitoh Y.; Kiriyama M.; Fukai I.; Yamakawa Y.; Mitsui A.; Toyama T.; Nemori R.; Fujii Y.

Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer
pp. 131-138(8)
Authors: Pujol J.-L.; Quantin X.; Jacot W.; Boher J.-M.; Grenier J.; Lamy P.-J.

Bcl-2 and bax expression in advanced non-small cell lung cancer: lack of correlation with chemotherapy response or survival in patients treated with docetaxel plus vinorelbine
pp. 139-143(5)
Authors: Krug L.M.; Miller V.A.; Filippa D.A.; Venkatraman E.; Ng K.K.; Kris M.G.

Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer
pp. 145-149(5)
Authors: Kanazawa S.; Nomura S.; Kuwana M.; Muramatsu M.; Yamaguchi K.; Fukuhara S.

The value of [¹⁸F]fluoro-2-deoxy-d-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment
pp. 151-157(7)
Authors: Hoekstra C.J.; Stroobants S.G.; Hoekstra O.S.; Vansteenkiste J.; Biesma B.; Schramel F.J.H.M.; van Zandwijk N.; van Tinteren H.; Smit E.F.

Correlation between lymph node micrometastasis and histologic classification of small lung adenocarcinomas, in considering the indication of limited surgery
pp. 159-164(6)
Authors: Ishiwa N.; Ogawa N.; Shoji A.; Maehara T.; Hayashi Y.; Takanashi Y.; Yazawa T.; Ito T.

Serum anti-p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non-neoplastic lung diseases
pp. 165-172(8)
Authors: Neri M.; Betta P.; Marroni P.; Filiberti R.; Cafferata M.; Mereu C.; Ivaldi G.; Montanaro F.; Puntoni R.; Paganuzzi M.

Concomitant weekly docetaxel, cisplatin and radiation therapy in locally advanced non-small cell lung cancer: a dose finding study
pp. 173-177(5)
Authors: Mudad R.; Ramsey M.; Kovitz K.; Curiel T.J.; Hartz R.; Nedzi L.L.; Weiner R.S.; Zakris E.L.

Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale
pp. 179-189(11)
Authors: Gebbia V.; Galetta D.; Caruso M.; Verderame F.; Pezzella G.; Valdesi M.; Borsellino N.; Pandolfo G.; Durini E.; Rinaldi M.; Loizzi M.; Gebbia N.; Valenza R.; Tirrito M.L.; Varvara F.; Colucci G.

A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer
pp. 191-196(6)
Authors: Winegarden J.D.; Mauer A.M.; Gajewski T.F.; Hoffman P.C.; Krauss S.; Rudin C.M.; Vokes E.E.

Phase 2 study of cryptophycin 52 ( LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer
pp. 197-199(3)
Authors: Edelman M.J.; Gandara D.R.; Hausner P.; Israel V.; Thornton D.; DeSanto J.; Doyle L.A.

Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study
pp. 201-207(7)
Authors: Cardenal F.; Domine M.; Massut B.; Carrato A.; Felip E.; Garrido P.; Juan O.; Artal A.; Barneto I.; Lopez-Vivanco G.; Balcells M.; Rosell R.

Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel
pp. 209-214(6)
Authors: Chen Y.-M.; Shih J.-F.; Lee C.-S.; Chen M.-C.; Lin W.-C.; Tsai C.-M.; Perng R.-P.

A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer
pp. 215-219(5)
Authors: Joppert M.G.; Garfield D.H.; Gregurich M.A.; Nemunaitis J.J.; Marsland T.A.; Khandelwal P.; Asmar L.

Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer
pp. 221-226(6)
Authors: Masters G.A.; Hahn E.A.; Shevrin D.H.; Kies M.S.

Endobronchial carcinoid tumor combined with pulmonary non-tuberculous mycobacterial infection: report of two cases
pp. 227-229(3)
Authors: Nakamura Y.; Okada Y.; Endo C.; Aikawa H.; Sakurada A.; Sato M.; Kondo T.

Early lung cancer action project pathology protocol
pp. 231-232(2)
Authors: Vazquez M.; Flieder D.; Travis W.; Carter D.; Yankelevitz D.F.; Miettinen O.S.; Henschke C.I.